Wiesbaden, Germany

Jana Podhorna

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jana Podhorna. Retrieved from https://idiyas.com/inventor/jana-podhorna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jana Podhorna and Her Work on Cognitive Impairment Associated with Schizophrenia.

Introduction

Jana Podhorna is an inventor based in Wiesbaden, Germany. Her patent work includes research into a potential treatment for cognitive impairment associated with schizophrenia.

Latest Patents

Podhorna is associated with 1 patent, titled “Treatment of Cognitive Impairment Associated with Schizophrenia.” The invention concerns using a specific GlyT1 inhibitor to treat cognitive impairment associated with schizophrenia. In a 12-week Phase 2 study, treatment was associated with improvement in cognitive function, measured by the overall composite score of the MATRICS Consensus Cognitive Battery (MCCB).

Career Highlights

Podhorna works at Boehringer Ingelheim International GmbH. Her patent reflects the company’s research into therapeutic approaches for cognitive symptoms associated with schizophrenia.

Collaborations

Her listed coworkers include Holger Rosenbrock and Yihua Zhao.

Conclusion

Jana Podhorna’s patent work focuses on a GlyT1 inhibitor investigated for its potential to improve cognitive function in people with schizophrenia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…